Meeting
2022 ASCO Annual Meeting
Candidate surrogate endpoints in advanced prostate cancer: Aggregate meta-analysis of 143 randomized trials.
Authors
Laila A Gharzai
Northwestern University, Chicago, IL
Laila A Gharzai , Ralph Jiang , Elizabeth Jaworski , Krystal A Morales , Robert Timothy Dess , William C. Jackson , Holly Hartman , Rohit Mehra , Amar Upadhyaya Kishan , Abhishek A Solanki , Edward M. Schaeffer , Felix Y Feng , Nicholas George Zaorsky , Alejandro Berlin , Lee Evan Ponsky , Jonathan Evan Shoag , Yilun Sun , Matthew J. Schipper , Jorge A. Garcia , Daniel Eidelberg Spratt
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer– Advanced/Castrate-Resistant
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 5039)
DOI
10.1200/JCO.2022.40.16_suppl.5039
Abstract #
5039
Poster Bd #
223
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Interaction of age and benefit of treatment intensification in advanced prostate cancer: An aggregate meta-analysis of 14 randomized trials.
First Author: Alicia K. Morgans
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Surrogate endpoints for overall survival in advanced hepatocellular carcinoma: A meta-analysis.
First Author: Yacob Saleh
Poster
2023 ASCO Annual Meeting
Progression-free survival as a surrogate endpoint of overall survival in advanced biliary tract cancer: A meta-analysis of randomized trials and individual-patient level correlation.
First Author: Carles Fabregat Franco
Poster
2018 Genitourinary Cancers Symposium
Is it the time to shift paradigms in castration naïve prostate cancer (CNPC): A meta-analysis of upfront docetaxel and abiraterone in men with CNPC.
First Author: Guangxi Sun